Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:32 ET | 36773 | 2.88 |
09:34 ET | 9436 | 2.915 |
09:36 ET | 26196 | 2.95 |
09:38 ET | 3575 | 2.945 |
09:39 ET | 3420 | 2.91 |
09:41 ET | 362 | 2.9335 |
09:43 ET | 4301 | 2.92 |
09:45 ET | 727 | 2.91 |
09:48 ET | 27951 | 2.93 |
09:50 ET | 21933 | 2.92 |
09:52 ET | 9993 | 2.925 |
09:54 ET | 15293 | 2.94 |
09:56 ET | 52753 | 2.86 |
09:57 ET | 2135 | 2.87 |
09:59 ET | 4636 | 2.88 |
10:01 ET | 23259 | 2.875 |
10:03 ET | 10836 | 2.885 |
10:06 ET | 2968 | 2.895 |
10:08 ET | 1798 | 2.885 |
10:10 ET | 34308 | 2.885 |
10:12 ET | 1198 | 2.885 |
10:14 ET | 2572 | 2.87 |
10:15 ET | 4446 | 2.86 |
10:17 ET | 1405 | 2.85 |
10:19 ET | 498 | 2.855 |
10:21 ET | 3158 | 2.865 |
10:24 ET | 1096 | 2.8603 |
10:26 ET | 11398 | 2.855 |
10:28 ET | 600 | 2.855 |
10:30 ET | 200 | 2.85 |
10:32 ET | 6485 | 2.84 |
10:33 ET | 3090 | 2.835 |
10:35 ET | 1645 | 2.84 |
10:37 ET | 700 | 2.845 |
10:39 ET | 2500 | 2.855 |
10:42 ET | 700 | 2.855 |
10:44 ET | 300 | 2.855 |
10:46 ET | 5899 | 2.835 |
10:50 ET | 2218 | 2.8201 |
10:51 ET | 15306 | 2.81 |
10:53 ET | 2955 | 2.805 |
10:55 ET | 5615 | 2.8097 |
10:57 ET | 34664 | 2.795 |
11:00 ET | 11192 | 2.805 |
11:02 ET | 3391 | 2.815 |
11:04 ET | 200 | 2.815 |
11:06 ET | 100 | 2.82 |
11:08 ET | 1774 | 2.82 |
11:09 ET | 100 | 2.82 |
11:11 ET | 650 | 2.82 |
11:13 ET | 2969 | 2.825 |
11:15 ET | 300 | 2.83 |
11:18 ET | 626 | 2.825 |
11:20 ET | 2723 | 2.815 |
11:22 ET | 1315 | 2.805 |
11:24 ET | 421 | 2.8 |
11:26 ET | 900 | 2.805 |
11:27 ET | 4100 | 2.815 |
11:29 ET | 3800 | 2.815 |
11:31 ET | 846 | 2.825 |
11:33 ET | 2305 | 2.82 |
11:36 ET | 700 | 2.815 |
11:38 ET | 5463 | 2.83 |
11:40 ET | 5204 | 2.825 |
11:42 ET | 6080 | 2.81 |
11:45 ET | 2100 | 2.8 |
11:47 ET | 800 | 2.805 |
11:49 ET | 3161 | 2.8063 |
11:51 ET | 1003 | 2.8 |
11:54 ET | 545 | 2.8 |
11:56 ET | 400 | 2.805 |
11:58 ET | 10216 | 2.795 |
12:00 ET | 7720 | 2.7936 |
12:02 ET | 778 | 2.78 |
12:03 ET | 3300 | 2.785 |
12:05 ET | 8425 | 2.77 |
12:07 ET | 1700 | 2.775 |
12:09 ET | 3900 | 2.775 |
12:12 ET | 10819 | 2.795 |
12:14 ET | 1373 | 2.795 |
12:20 ET | 100 | 2.795 |
12:21 ET | 100 | 2.795 |
12:23 ET | 2827 | 2.785 |
12:25 ET | 300 | 2.785 |
12:27 ET | 4231 | 2.785 |
12:30 ET | 508 | 2.785 |
12:32 ET | 100 | 2.785 |
12:34 ET | 31598 | 2.785 |
12:36 ET | 571 | 2.785 |
12:38 ET | 584 | 2.785 |
12:39 ET | 8107 | 2.795 |
12:41 ET | 100 | 2.795 |
12:43 ET | 100 | 2.795 |
12:45 ET | 200 | 2.795 |
12:48 ET | 300 | 2.795 |
12:50 ET | 100 | 2.79 |
12:52 ET | 3467 | 2.78 |
12:54 ET | 3050 | 2.785 |
12:56 ET | 100 | 2.785 |
12:57 ET | 2426 | 2.79 |
12:59 ET | 7637 | 2.8 |
01:01 ET | 411 | 2.795 |
01:06 ET | 100 | 2.795 |
01:08 ET | 3200 | 2.795 |
01:10 ET | 2300 | 2.7997 |
01:12 ET | 100 | 2.795 |
01:14 ET | 427 | 2.795 |
01:15 ET | 100 | 2.795 |
01:17 ET | 100 | 2.795 |
01:21 ET | 2200 | 2.795 |
01:24 ET | 5371 | 2.785 |
01:26 ET | 100 | 2.785 |
01:28 ET | 16899 | 2.79 |
01:30 ET | 100 | 2.785 |
01:32 ET | 100 | 2.78 |
01:33 ET | 384 | 2.79 |
01:35 ET | 102 | 2.785 |
01:37 ET | 39845 | 2.785 |
01:39 ET | 9662 | 2.79 |
01:42 ET | 100 | 2.795 |
01:44 ET | 300 | 2.795 |
01:48 ET | 500 | 2.795 |
01:50 ET | 22653 | 2.825 |
01:51 ET | 818 | 2.825 |
01:53 ET | 8667 | 2.825 |
01:55 ET | 800 | 2.825 |
01:57 ET | 9069 | 2.8 |
02:00 ET | 300 | 2.805 |
02:02 ET | 200 | 2.805 |
02:04 ET | 577 | 2.805 |
02:06 ET | 14708 | 2.805 |
02:08 ET | 400 | 2.8099 |
02:09 ET | 400 | 2.805 |
02:11 ET | 204 | 2.805 |
02:13 ET | 709 | 2.805 |
02:15 ET | 15720 | 2.805 |
02:18 ET | 6430 | 2.8 |
02:20 ET | 4750 | 2.795 |
02:22 ET | 200 | 2.795 |
02:24 ET | 595 | 2.795 |
02:26 ET | 404 | 2.795 |
02:27 ET | 490 | 2.79 |
02:29 ET | 600 | 2.795 |
02:31 ET | 897 | 2.795 |
02:33 ET | 19235 | 2.79 |
02:38 ET | 7253 | 2.78 |
02:40 ET | 556 | 2.78 |
02:42 ET | 8179 | 2.785 |
02:45 ET | 153 | 2.785 |
02:47 ET | 6736 | 2.775 |
02:49 ET | 7294 | 2.775 |
02:54 ET | 1802 | 2.785 |
02:56 ET | 671 | 2.785 |
02:58 ET | 300 | 2.785 |
03:00 ET | 700 | 2.785 |
03:02 ET | 400 | 2.785 |
03:03 ET | 2552 | 2.775 |
03:05 ET | 6665 | 2.765 |
03:07 ET | 2300 | 2.7672 |
03:09 ET | 8003 | 2.7799 |
03:12 ET | 2585 | 2.78 |
03:14 ET | 300 | 2.775 |
03:16 ET | 1100 | 2.775 |
03:20 ET | 4776 | 2.785 |
03:21 ET | 6584 | 2.775 |
03:23 ET | 700 | 2.78 |
03:25 ET | 900 | 2.775 |
03:27 ET | 4827 | 2.78 |
03:30 ET | 1011 | 2.785 |
03:32 ET | 4846 | 2.795 |
03:34 ET | 7801 | 2.795 |
03:36 ET | 15287 | 2.8 |
03:38 ET | 2113 | 2.8 |
03:39 ET | 1123 | 2.795 |
03:41 ET | 2118 | 2.8 |
03:43 ET | 1035 | 2.8 |
03:45 ET | 2849 | 2.8 |
03:48 ET | 18361 | 2.795 |
03:50 ET | 12241 | 2.795 |
03:52 ET | 43525 | 2.8 |
03:54 ET | 24805 | 2.8 |
03:56 ET | 33514 | 2.8 |
03:57 ET | 11750 | 2.8 |
03:59 ET | 188634 | 2.8 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 697.9M | -1.3x | --- |
Replimune Group Inc | 701.7M | -3.1x | --- |
ProKidney Corp | 692.3M | -4.0x | --- |
Oric Pharmaceuticals Inc | 692.0M | -5.6x | --- |
Olema Pharmaceuticals Inc | 710.1M | -6.0x | --- |
Lexicon Pharmaceuticals Inc | 690.5M | -2.5x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $697.9M |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 249.2M |
Nuvation Bio Inc does not pay a dividend. | |
Beta | 1.38 |
EPS | $-2.11 |
Book Value | $2.76 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 486.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,474.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.